Yan Shan Ang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Shan Ang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Lin-Yue Lanry Yung
National University of Singapore
11 shared publications Yahui Gao
Department of Chemical & Biomolecular Engineering
2 shared publicationsDionne Ker Xin Low
Aproxy Pte. Ltd. 33A Pagoda Street Singapore 059192 Singapore
1 shared publicationHong Meng Yam
NUS High School of Mathematics and Science
1 shared publication- Ningjing Wu
NUS High School of Mathematics and Science
1 shared publication - Poh San Lai
National University of Singapore, Singapore
1 shared publication
Latest Publications
- 4 September 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (36) , 26421-26429
A Signal Turn-On DNA Proximity Assay That Correlates with SARS-CoV-2 Blocking Antibody Levels
Surrogate in vitro assays have enabled the scalable testing of neutralizing antibodies to SARS-CoV-2 as a toolbox to manage the post-COVID-19 situation and future outbreaks. However, most surrogate assays use a competitive format to mimic the blocking event between the receptor binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor. This signal “turn-off” format has a narrow dynamic range and is semiquantitative at best. In this proof-of-concept work, we introduce a signal “turn-on” dual antigen assay based on the proximity activation of a pair of RBD-oligonucleotide initiator probes upon bridging by the target antibody. Three well-characterized SARS-CoV-2 variants, i.e., 2019 (wild-type), Delta (B.1.617.2), and Omicron (B.1.1.529), were tested against three commercial antibodies with known RBD-binding and ACE2-blocking profiles. The DNA proximity assay (DPA) results correlated with the ability of the antibodies to block ACE2 instead of their binding to the RBD. Moreover, the single-step, wash-free property of DPA enabled quantification using the kinetic rate of fluorescence signal generation which was more robust than conventional end-point measurements. The DPA achieved good analytical performance with ng/mL detection limit and high assay precision (<5% interassay coefficient of variation), as well as good spike-and-recovery and dilution linearity in serum matrix. The test outcome from three sets of validated vaccine time-series samples were concordant with reference values, demonstrating the potential clinical utility of the DPA platform.
- 4 September 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (36) , 26421-26429
A Signal Turn-On DNA Proximity Assay That Correlates with SARS-CoV-2 Blocking Antibody Levels
Surrogate in vitro assays have enabled the scalable testing of neutralizing antibodies to SARS-CoV-2 as a toolbox to manage the post-COVID-19 situation and future outbreaks. However, most surrogate assays use a competitive format to mimic the blocking event between the receptor binding domain (RBD) and the human angiotensin-converting enzyme 2 (ACE2) receptor. This signal “turn-off” format has a narrow dynamic range and is semiquantitative at best. In this proof-of-concept work, we introduce a signal “turn-on” dual antigen assay based on the proximity activation of a pair of RBD-oligonucleotide initiator probes upon bridging by the target antibody. Three well-characterized SARS-CoV-2 variants, i.e., 2019 (wild-type), Delta (B.1.617.2), and Omicron (B.1.1.529), were tested against three commercial antibodies with known RBD-binding and ACE2-blocking profiles. The DNA proximity assay (DPA) results correlated with the ability of the antibodies to block ACE2 instead of their binding to the RBD. Moreover, the single-step, wash-free property of DPA enabled quantification using the kinetic rate of fluorescence signal generation which was more robust than conventional end-point measurements. The DPA achieved good analytical performance with ng/mL detection limit and high assay precision (<5% interassay coefficient of variation), as well as good spike-and-recovery and dilution linearity in serum matrix. The test outcome from three sets of validated vaccine time-series samples were concordant with reference values, demonstrating the potential clinical utility of the DPA platform.
- 18 July 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (30) , 21115-21127
Sequence Engineering of Guide DNA for Precise RNA Targeting by Cas12a
Cas12a is highly accommodative toward noncanonical activation pathways to the extent of flipping its identity to be a DNA-guided RNA-targeting effector. A sequence engineering approach was used to systematically identify desirable guide DNA (gDNA) sequence motifs to achieve comparable RNA targeting efficiency as the canonical RNA-guided Cas12a with good selectivity down to single-nucleotide mismatch. Importantly, we introduced a split gDNA design concept with greater energetic differences arising from subtle nucleotide changes to probe the key spacer features for effective Cas12a-gDNA activation. Similar to the canonical RNA-guided activation pathway, Cas12a was found to engage actively in the “seed-like” scaffold-proximal region while the scaffold-distal region was largely hybridization-driven. We further evolved the split gDNA design to enhance the sequence selectivity by up to 21-fold compared to a single gDNA design and achieve single-nucleotide discrimination among representative let-7 family members. This study has established a gDNA sequence design framework to reprogram Cas12a as a precise RNA targeting platform.
- 18 July 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (30) , 21115-21127
Sequence Engineering of Guide DNA for Precise RNA Targeting by Cas12a
Cas12a is highly accommodative toward noncanonical activation pathways to the extent of flipping its identity to be a DNA-guided RNA-targeting effector. A sequence engineering approach was used to systematically identify desirable guide DNA (gDNA) sequence motifs to achieve comparable RNA targeting efficiency as the canonical RNA-guided Cas12a with good selectivity down to single-nucleotide mismatch. Importantly, we introduced a split gDNA design concept with greater energetic differences arising from subtle nucleotide changes to probe the key spacer features for effective Cas12a-gDNA activation. Similar to the canonical RNA-guided activation pathway, Cas12a was found to engage actively in the “seed-like” scaffold-proximal region while the scaffold-distal region was largely hybridization-driven. We further evolved the split gDNA design to enhance the sequence selectivity by up to 21-fold compared to a single gDNA design and achieve single-nucleotide discrimination among representative let-7 family members. This study has established a gDNA sequence design framework to reprogram Cas12a as a precise RNA targeting platform.
DNA‐Programmed Reaction to Evaluate Specific IgE for Allergy Point‐of‐Care Testing
A DNA‐programmed reaction to evaluate non‐nucleic acids inputs with computation speed (≈30 min) and sensitivity (sub‐picomolar) suitable for analyzing physiologically relevant biomarkers in a one‐pot format and point‐of‐care testing setting is reported. Specifically, a DNA programme based on the proximity‐activation exponential amplification reaction (PEAR) is designed to evaluate specific IgE (sIgE) against Der p 2 implicated in dust mite allergy which affects millions worldwide. In this work, we tailored the molecular components of the input‐to‐oligo barcode conversion module as an AND gate to detect inputs with binding specificity to Der p 2 antigen and is of an IgE isotype. In addition, an in situ biotinylation method is developed to generate amplified oligo barcodes amendable for direct visualization on a lateral flow format. As a proof‐of‐concept demonstration of its potential clinical utility, 21 clinical samples are evaluated by the as‐developed sIgE PEAR programme using the dual readout modality of real‐time fluorescence measurement for precise input quantification and simple lateral flow yes/no answer.
DNA‐Programmed Reaction to Evaluate Specific IgE for Allergy Point‐of‐Care Testing
A DNA‐programmed reaction to evaluate non‐nucleic acids inputs with computation speed (≈30 min) and sensitivity (sub‐picomolar) suitable for analyzing physiologically relevant biomarkers in a one‐pot format and point‐of‐care testing setting is reported. Specifically, a DNA programme based on the proximity‐activation exponential amplification reaction (PEAR) is designed to evaluate specific IgE (sIgE) against Der p 2 implicated in dust mite allergy which affects millions worldwide. In this work, we tailored the molecular components of the input‐to‐oligo barcode conversion module as an AND gate to detect inputs with binding specificity to Der p 2 antigen and is of an IgE isotype. In addition, an in situ biotinylation method is developed to generate amplified oligo barcodes amendable for direct visualization on a lateral flow format. As a proof‐of‐concept demonstration of its potential clinical utility, 21 clinical samples are evaluated by the as‐developed sIgE PEAR programme using the dual readout modality of real‐time fluorescence measurement for precise input quantification and simple lateral flow yes/no answer.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 977-985
CRISPR-Cas12a-Assisted DNA Circuit for Nonmicroscopic Detection of Cell Surface Receptor Clustering
Protein-protein interactions (PPIs) on the cell surface have been of great interest due to their high clinical relevance and significance; however, the methods for detecting PPIs heavily rely on microscopic instruments. In this work, we designed a Cas12a-assisted DNA circuit for detecting cell surface receptor clustering events without a dependence on microscopy. This nonmicroscopic approach is based on the proximity principle, where localized protein-protein interactions such as receptor clustering are converted into DNA barcodes. These barcodes can then be identified by Cas12a for signal generation in the bulk. The compatibility of the circuit with Cas12a was first experimentally verified. Several leak reactions were identified and minimized. Lastly, we implemented this design in human breast cancer cell line models to distinguish the different levels of human epidermal growth factor receptor 2 (HER2) homodimers and heterodimers with HER1 and HER3 semiquantitatively without the use of a microscope. Overall, our proposed Cas12a-assisted DNA circuit for detecting cell surface receptor clustering shows the potential for fast screening in diagnostic applications and drug discovery, demonstrating the promising use of enzymatic DNA circuits in biological applications.
- 10 February 2025
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 10 (2) , 977-985
CRISPR-Cas12a-Assisted DNA Circuit for Nonmicroscopic Detection of Cell Surface Receptor Clustering
Protein-protein interactions (PPIs) on the cell surface have been of great interest due to their high clinical relevance and significance; however, the methods for detecting PPIs heavily rely on microscopic instruments. In this work, we designed a Cas12a-assisted DNA circuit for detecting cell surface receptor clustering events without a dependence on microscopy. This nonmicroscopic approach is based on the proximity principle, where localized protein-protein interactions such as receptor clustering are converted into DNA barcodes. These barcodes can then be identified by Cas12a for signal generation in the bulk. The compatibility of the circuit with Cas12a was first experimentally verified. Several leak reactions were identified and minimized. Lastly, we implemented this design in human breast cancer cell line models to distinguish the different levels of human epidermal growth factor receptor 2 (HER2) homodimers and heterodimers with HER1 and HER3 semiquantitatively without the use of a microscope. Overall, our proposed Cas12a-assisted DNA circuit for detecting cell surface receptor clustering shows the potential for fast screening in diagnostic applications and drug discovery, demonstrating the promising use of enzymatic DNA circuits in biological applications.
- 30 July 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (8) , 3928-3937
One-Pot Detection of Proteins Using a Two-Way Extension-Based Assay with Cas12a
Protein biomarkers are an important class of biomarkers in disease diagnosis and are traditionally detected by enzyme-linked immunosorbent assay and mass spectrometry, which involve multiple steps and a complex workflow. In recent years, many CRISPR-Cas12a-based methods for protein detection have been developed; however, most of them have not overcome the workflow complications observed in traditional assays, limiting their applicability in point-of-care testing. In this work, we designed a single-step, one-pot, and proximity-based isothermal immunoassay integrating CRISPR Cas12a for homogeneous protein target detection with a simplified workflow and high sensitivity. Probes consisting of different binders (small molecule, aptamer, and antibody) conjugated with oligonucleotides undergo two-way extension upon binding to the protein targets, leading to downstream DNA amplification by a pair of nicking enzymes and polymerases to generate target sequences for Cas12a signal generation. We used the streptavidin-biotin model to demonstrate the design of our assay and proved that all three elements of protein detection (target protein binding, DNA amplification, and Cas12a signal generation) could coexist in one pot and proceed isothermally in a single buffer system at a low reaction volume of 10 μL. The plug-and-play applicability of our assay has been successfully demonstrated using four different protein targets, streptavidin, PDGF-BB, antidigoxigenin antibody, and IFNγ, with the limit of detection ranging from fM to pM.
- 30 July 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (8) , 3928-3937
One-Pot Detection of Proteins Using a Two-Way Extension-Based Assay with Cas12a
Protein biomarkers are an important class of biomarkers in disease diagnosis and are traditionally detected by enzyme-linked immunosorbent assay and mass spectrometry, which involve multiple steps and a complex workflow. In recent years, many CRISPR-Cas12a-based methods for protein detection have been developed; however, most of them have not overcome the workflow complications observed in traditional assays, limiting their applicability in point-of-care testing. In this work, we designed a single-step, one-pot, and proximity-based isothermal immunoassay integrating CRISPR Cas12a for homogeneous protein target detection with a simplified workflow and high sensitivity. Probes consisting of different binders (small molecule, aptamer, and antibody) conjugated with oligonucleotides undergo two-way extension upon binding to the protein targets, leading to downstream DNA amplification by a pair of nicking enzymes and polymerases to generate target sequences for Cas12a signal generation. We used the streptavidin-biotin model to demonstrate the design of our assay and proved that all three elements of protein detection (target protein binding, DNA amplification, and Cas12a signal generation) could coexist in one pot and proceed isothermally in a single buffer system at a low reaction volume of 10 μL. The plug-and-play applicability of our assay has been successfully demonstrated using four different protein targets, streptavidin, PDGF-BB, antidigoxigenin antibody, and IFNγ, with the limit of detection ranging from fM to pM.
- 4 April 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (15) , 10454-10463
Protein-to-DNA Converter with High Signal Gain
DNA isothermal amplification techniques have been applied extensively for evaluating nucleic acid inputs but cannot be implemented directly on other types of biomolecules. In this work, we designed a proximity activation mechanism that converts protein input into DNA barcodes for the DNA exponential amplification reaction, which we termed PEAR. Several design parameters were identified and experimentally verified, which included the choice of enzymes, sequences of proximity probes and template strand via the NUPACK design tool, and the implementation of a hairpin lock on the proximity probe structure. Our PEAR system was surprisingly more robust against nonspecific DNA amplification, which is a major challenge faced in existing formats of the DNA-based exponential amplification reaction. The as-designed PEAR exhibited good target responsiveness for three protein models with a dynamic range of 4–5 orders of magnitude down to femtomolar input concentration. Overall, our proposed protein-to-DNA converter module led to the development of a stable and robust configuration of the DNA exponential amplification reaction to achieve high signal gain. We foresee this enabling the use of protein inputs for more complex molecular evaluation as well as ultrasensitive protein detection.
- 4 April 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (15) , 10454-10463
Protein-to-DNA Converter with High Signal Gain
DNA isothermal amplification techniques have been applied extensively for evaluating nucleic acid inputs but cannot be implemented directly on other types of biomolecules. In this work, we designed a proximity activation mechanism that converts protein input into DNA barcodes for the DNA exponential amplification reaction, which we termed PEAR. Several design parameters were identified and experimentally verified, which included the choice of enzymes, sequences of proximity probes and template strand via the NUPACK design tool, and the implementation of a hairpin lock on the proximity probe structure. Our PEAR system was surprisingly more robust against nonspecific DNA amplification, which is a major challenge faced in existing formats of the DNA-based exponential amplification reaction. The as-designed PEAR exhibited good target responsiveness for three protein models with a dynamic range of 4–5 orders of magnitude down to femtomolar input concentration. Overall, our proposed protein-to-DNA converter module led to the development of a stable and robust configuration of the DNA exponential amplification reaction to achieve high signal gain. We foresee this enabling the use of protein inputs for more complex molecular evaluation as well as ultrasensitive protein detection.
- Open Access
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (88) , 13167-13170
Design strategies for countering the effect of fluorophore-quencher labelling on DNA hairpin thermodynamics
Fluorophore-quencher labelling induced a significant impact on the DNA hairpin opening thermodynamics. Two practical design strategies to counter this effect are reported.
- 12 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 59 (88) , 13167-13170
Open AccessDesign strategies for countering the effect of fluorophore-quencher labelling on DNA hairpin thermodynamics
Fluorophore-quencher labelling induced a significant impact on the DNA hairpin opening thermodynamics. Two practical design strategies to counter this effect are reported.
- 31 July 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (32) , 12071-12079
Protein–DNA Conjugates with a Discrete Number of Oligonucleotide Strands for Highly Reproducible Protein Quantification by the DNA Proximity Assay
Protein-oligonucleotide conjugates are increasingly used as detection probes in biological applications such as proximity sensing and spatial biology. The preparation of high-quality conjugate probes as starting reagents is critical for achieving good and consistent performance, which we demonstrate via the DNA proximity assay (DPA) for the one-pot quantification of protein targets. We first established a complete conjugation and anion-exchange chromatography purification workflow to reproducibly obtain pure subpopulations of protein probes carrying a discrete number of oligonucleotide strands. A systematic study using the purified conjugate sub-populations confirmed that the order of conjugate (number of oligonucleotides per protein) and its purity (the absence of the unconjugated antibody) were important for ensuring optimal and reproducible assay performance. The streamlined workflow was then successfully used to conjugate a pair of universal DPA initiator oligonucleotides onto a wide range of binders including antibodies, nanobodies, and antigens which enabled the versatile detection of different types of proteins such as cytokines, total antibodies, and specific antibody isotypes. The good assay robustness (the inter-assay coefficient of variation lower than 5%) and linear calibration curve was achieved across all targets with just a single mix-and-incubate reaction step and a short reaction time of 30 min. We anticipate the streamlined protein-oligonucleotide probe preparation workflow developed in this work to have broad utility across applications leveraging the specificity of protein bio-recognition with the programmability of DNA hybridization.
- 31 July 2023
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (32) , 12071-12079
Protein–DNA Conjugates with a Discrete Number of Oligonucleotide Strands for Highly Reproducible Protein Quantification by the DNA Proximity Assay
Protein-oligonucleotide conjugates are increasingly used as detection probes in biological applications such as proximity sensing and spatial biology. The preparation of high-quality conjugate probes as starting reagents is critical for achieving good and consistent performance, which we demonstrate via the DNA proximity assay (DPA) for the one-pot quantification of protein targets. We first established a complete conjugation and anion-exchange chromatography purification workflow to reproducibly obtain pure subpopulations of protein probes carrying a discrete number of oligonucleotide strands. A systematic study using the purified conjugate sub-populations confirmed that the order of conjugate (number of oligonucleotides per protein) and its purity (the absence of the unconjugated antibody) were important for ensuring optimal and reproducible assay performance. The streamlined workflow was then successfully used to conjugate a pair of universal DPA initiator oligonucleotides onto a wide range of binders including antibodies, nanobodies, and antigens which enabled the versatile detection of different types of proteins such as cytokines, total antibodies, and specific antibody isotypes. The good assay robustness (the inter-assay coefficient of variation lower than 5%) and linear calibration curve was achieved across all targets with just a single mix-and-incubate reaction step and a short reaction time of 30 min. We anticipate the streamlined protein-oligonucleotide probe preparation workflow developed in this work to have broad utility across applications leveraging the specificity of protein bio-recognition with the programmability of DNA hybridization.
- 12 May 2021
- Published by Springer Nature
- p. 599-608
DNA Proximity Circuit a Universal Platform for Analyzing Biomarkers
- 12 May 2021
- Published by Springer Nature
- p. 599-608
DNA Proximity Circuit a Universal Platform for Analyzing Biomarkers
- Open Access
- 13 April 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (8) , 4258-4265
Dynamically elongated associative toehold for tuning DNA circuit kinetics and thermodynamics
Associative toehold is a powerful concept enabling efficient combinatorial computation in DNA circuit. A longer association length boosts circuit kinetics and equilibrium signal but results in higher leak rate. We reconcile this trade-off by using a hairpin lock design to dynamically elongate the effective associative toehold length in response to the input target. Design guidelines were established to achieve robust elongation without incurring additional leakages. Three hairpin initiators with different combinations of elongated associative toehold (4 → 6 nt, 5 → 8 nt and 6 → 9 nt) were shortlisted from the design framework for further discussion. The circuit performance improved in terms of reaction kinetics, equilibrium signal generated and limit of detection. Overall, the elongated associative toehold served as a built-in function to stabilize and favour the forward, desired reaction when triggered.
- 13 April 2021
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 49 (8) , 4258-4265
Open AccessDynamically elongated associative toehold for tuning DNA circuit kinetics and thermodynamics
Associative toehold is a powerful concept enabling efficient combinatorial computation in DNA circuit. A longer association length boosts circuit kinetics and equilibrium signal but results in higher leak rate. We reconcile this trade-off by using a hairpin lock design to dynamically elongate the effective associative toehold length in response to the input target. Design guidelines were established to achieve robust elongation without incurring additional leakages. Three hairpin initiators with different combinations of elongated associative toehold (4 → 6 nt, 5 → 8 nt and 6 → 9 nt) were shortlisted from the design framework for further discussion. The circuit performance improved in terms of reaction kinetics, equilibrium signal generated and limit of detection. Overall, the elongated associative toehold served as a built-in function to stabilize and favour the forward, desired reaction when triggered.